PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
08-Mar-2022 M&F HEALTH JOINS CLIENT ORGANON IN GIVING ALL EMPLOYEES A DAY OFF TO FOCUS ON THEIR HEALTH ON INTERNATIONAL WOMEN’S DAY 2022 M&F HEALTH
08-Mar-2022 Know Labs Provides 2022 Outlook, Outlines Preparations for Pre-Submission Meeting with FDA Businesswire
08-Mar-2022 TXOG’s PTSD Focus Group Shows 71% of Patients Achieved PTSD Remission with Medical Cannabis Businesswire
08-Mar-2022 New AI and medical scanning study could end the need for invasive surgery to diagnose endometriosis NCIMI
08-Mar-2022 DNAnexus Secures $200 Million Funding Led by Blackstone Growth to Advance its Biomedical Data-Driven Technology Platform for Precision Medicine Businesswire
08-Mar-2022 Emulate Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2022 Businesswire
08-Mar-2022 Evolus to Participate in the Barclays Global Healthcare Conference Businesswire
08-Mar-2022 Simulations Plus to Present at Oppenheimer Annual Healthcare Conference Businesswire
08-Mar-2022 Biocept Appoints Philippe Marchand as Chief Operating Officer Businesswire
08-Mar-2022 PROS Industry-Leading Pricing Advances Global Business Strategy for B Braun Medical Businesswire
08-Mar-2022 New, Innovative GC and GC-MS Product Portfolio Enables Greater Uptime and Efficiency Businesswire
08-Mar-2022 Palleon Pharmaceuticals Announces First Patient Dosed in Phase 1/2 Study of Lead Glyco-Immunology Drug Candidate for Oncology Businesswire
08-Mar-2022 Mytide Therapeutics Raises $7 Million Series A Round to Transform Peptide Manufacturing with Machine Learning Businesswire
08-Mar-2022 Sarcoma Trial for New Cancer Treatment Begins at City of Hope in Los Angeles Businesswire
08-Mar-2022 Genexa Named Fast Company’s No. 1 Most Innovative Company in Wellness for 2022 Businesswire
08-Mar-2022 TRexBio Completes $26 Million Series A Extension Led by Polaris Partners to Advance Treatments for Immune-Mediated Diseases Businesswire
08-Mar-2022 Variscite Subverts Component Crises with Launch of Additional Production Line Businesswire
08-Mar-2022 Aldeyra Therapeutics Initiates Phase 2 Clinical Trial of ADX-2191 for the Treatment of Retinitis Pigmentosa Businesswire
08-Mar-2022 Revance Resubmits Biologics License Application for DaxibotulinumtoxinA for Injection for Glabellar Lines to the FDA Businesswire
08-Mar-2022 Inspirna to Participate in Multiple Virtual Healthcare Investor Conferences in March Businesswire